Dennis A. Smith
Nature reviews. Drug discovery · 2010–2016
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Dennis A. Smith trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Dennis A. Smith's perspective
Ordered by how strongly the researchers Dennis A. Smith trusts endorse each paper. Same corpus, a different order for every researcher.
- Drug penetration in solid tumours (Nature Reviews. Cancer)
- Changes in plasma protein binding have little clinical relevance (Clinical pharmacology and therapy)
- Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine (Clinical pharmacology and therapy)
- The superfamily of organic anion transporting polypeptides. (Biochimica et Biophysica Acta)
- Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. (Molecular Pharmaceutics)
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (Journal of Clinical Investigation)
- Drug interactions with lipid‐lowering drugs: Mechanisms and clinical relevance (Clinical pharmacology and therapy)
- Molecular properties that influence the oral bioavailability of drug candidates. (Journal of Medicinal Chemistry)
- Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions (Pharmaceutical Research)
- Absorption classification of oral drugs based on molecular surface properties.